Discover 10 dividend stocks with strong performance in 2025. Ranked by YTD returns, these stocks excel in safety, growth, yield & consistency.
For the quarter ended December 2024, BioCryst Pharmaceuticals (BCRX) reported revenue of $131.53 million, up 40.8% over the same period last year. EPS came in at -$0.13, compared to -$0.28 in the year ...
In its upcoming report, California Resources Corporation (CRC) is predicted by Wall Street analysts to post quarterly earnings of $0.96 per share, reflecting an increase of 3.2% compared to the same ...
NEW YORK — Global markets buckled up for a turbulent session on Monday after President Donald Trump launched a trade war with sweeping tariffs on Canada, Mexico, and China that threaten ...